Cargando…
Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
Tumor necrosis factor-α (TNFα) inhibition is an effective treatment of moderate-to-severe psoriasis and other diseases (rheumatoid arthritis, ankylosing spondylitis, psoriasis or Crohn's disease). We report a case of a 32-years-old patient affected by Crohn's disease since the age of 25 wh...
Autores principales: | Mola, Federica, Motolese, Alberico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211513/ https://www.ncbi.nlm.nih.gov/pubmed/25386292 http://dx.doi.org/10.4081/dr.2011.e40 |
Ejemplares similares
-
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018) -
Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2023) -
Genital and Intertriginous Rashes Refractory to Antimicrobial Treatments: Have You Thought about Crohn's Disease?
por: O'Farrell, Candelaria, et al.
Publicado: (2021) -
Infliximab-Induced Aseptic Meningitis in a Patient with Crohn’s Disease
por: Junga, Zachary, et al.
Publicado: (2018) -
Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)